Acute Zonal Occult Outer Retinopathy (AZOOR)

Patient Tools

Read, save, and share this guide

Use these quick tools to make this medical article easier to read, print, save, or share with a family member.

Medical guide Rx Eye & Vision Care (A - Z) Feb 8, 2026 67 reads
Related reading

Patient Mode

Understand this article easily

Switch between simple English and easy Bangla patient notes. This is for education and does not replace a doctor consultation.

Acute Zonal Occult Outer Retinopathy (AZOOR) is a rare retinal disease first described by J. Donald Gass in 1992. It is classified within the “white dot syndromes” and is characterized by the acute onset of one or more large zones of outer retinal dysfunction, typically...

For severe symptoms, danger signs, pregnancy, child illness, or sudden worsening, seek urgent medical care.

বাংলা রোগী নোট এখনো যোগ করা হয়নি। পোস্ট এডিটরে “RX Bangla Patient Mode” বক্স থেকে সহজ বাংলা সারাংশ যোগ করুন।

এই তথ্য শিক্ষা ও সচেতনতার জন্য। এটি ডাক্তারি পরীক্ষা, রোগ নির্ণয় বা প্রেসক্রিপশনের বিকল্প নয়।

Article Summary

Acute Zonal Occult Outer Retinopathy (AZOOR) is a rare retinal disease first described by J. Donald Gass in 1992. It is classified within the “white dot syndromes” and is characterized by the acute onset of one or more large zones of outer retinal dysfunction, typically presenting with photopsias (“flashing lights”) and scotomas (“blind spots”) despite a largely normal-appearing fundus upon examination Wikipediajournals.lww.com. Acute Zonal Occult...

Key Takeaways

  • This article explains Types of AZOOR in simple medical language.
  • This article explains Proposed Causes in simple medical language.
  • This article explains Symptoms in simple medical language.
  • This article explains Diagnostic Tests in simple medical language.
Educational health guideWritten for patient understanding and clinical awareness.
Reviewed content workflowUse writer and reviewer profiles for stronger trust.
Emergency safety firstUrgent warning signs are highlighted below.

Seek urgent medical care if you notice

These warning signs are general safety guidance. Local emergency numbers and clinical judgment should always come first.

  • Sudden vision loss, severe eye pain, new flashes, or many new floaters.
  • Eye symptoms after injury or chemical exposure.
  • Rapidly worsening redness, swelling, or vision changes.
1

Emergency now

Use emergency care for severe, sudden, rapidly worsening, or life-threatening symptoms.

2

See a doctor

Book a professional medical evaluation if symptoms persist, worsen, recur often, affect daily activities, or occur in a high-risk patient.

3

Learn safely

Use this article to understand possible causes, tests, treatment options, prevention, and questions to ask your clinician.

Before reading

RX Patient Tools

Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.

Start here Choose the right pathway for symptoms, reports, medicines, or urgent warning signs. Disease article roadmap Read this topic step by step: meaning, symptoms, warning signs, diagnosis, treatment, prevention, and follow-up. Treatment planner Prepare questions about treatment choices, benefits, risks, side effects, and follow-up. Family & caregiver guide Organize symptoms, reports, medicines, questions, and follow-up safely. Nutrition & diet guide Prepare food, hydration, supplement, and medicine-timing questions safely. Prevention guide Organize risk factors, protective habits, screening, and warning signs. Recovery guide Prepare a safe plan for activity, rehabilitation, warning signs, and follow-up.
Definition

Acute Zonal Occult Outer Retinopathy (AZOOR) is a rare retinal disease first described by J. Donald Gass in 1992. It is classified within the “white dot syndromes” and is characterized by the acute onset of one or more large zones of outer retinal dysfunction, typically presenting with photopsias (“flashing lights”) and scotomas (“blind spots”) despite a largely normal-appearing fundus upon examination Wikipediajournals.lww.com.

Acute Zonal Occult Outer Retinopathy (AZOOR) is a rare, idiopathic inflammatory retinopathy characterized by sudden dysfunction of the outer retina, particularly the photoreceptor layer, leading to acute visual field defects and photopsias with initially minimal funduscopic changes. First described by Donald Gass in 1992, it predominantly affects young to middle-aged adults, with a strong female preponderance, and often presents with abrupt onset of “whitening” or blurring of vision and persistent scintillations in one or more large zones of the visual field Wikipedia. Electroretinography typically shows reduced outer retinal responses, and multimodal imaging (optical coherence tomography, fundus autofluorescence) reveals zonal disruptions in the ellipsoid zone and irregular autofluorescence patterns EyeWiki.

AZOOR is grouped within the “white dot syndromes,” though its fundus appearance may remain unremarkable early on. Over weeks to months, patients can develop peripapillary grayish-white lines and pigmentary changes at the border of affected zones. Visual acuity may be preserved despite marked scotomas, and the disease can progress to involve the fellow eye in a significant proportion of cases ajo.com. The exact etiology remains unknown, with hypotheses including a viral trigger or immune-mediated attack on photoreceptors.

Patients with AZOOR exhibit functional loss of photoreceptors with minimal or delayed pigmentary changes in the retinal pigment epithelium (RPE). Electroretinography (ERG) shows global cone-system delays, and fundus autofluorescence (FAF) and optical coherence tomography (OCT) reveal a characteristic “trizonal” pattern of involvement: (1) normal autofluorescence outside the ulcer. সহজ বাংলা: শরীরের অস্বাভাবিক দাগ, ক্ষত বা ফোলা অংশ।" data-rx-term="lesion" data-rx-definition="A lesion is an abnormal area of tissue such as a spot, wound, patch, lump, or ulcer. সহজ বাংলা: শরীরের অস্বাভাবিক দাগ, ক্ষত বা ফোলা অংশ।">lesion; (2) speckled hyperautofluorescence within the lesion; and (3) hypoautofluorescence indicating RPE atrophy in advanced zones EyeWikiEyeWiki.

AZOOR predominantly affects young to middle-aged adults—especially Caucasian females in their 30s—though it can occur at any age and in all ethnicities. Its exact etiology remains unknown, but prevailing theories implicate autoimmune and viral triggers leading to outer retinal infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation and photoreceptor damage EyeWikijournals.lww.com.


Types of AZOOR

Type 1 (Primary AZOOR):
This form presents as an isolated zonal loss of outer retinal function without preceding white dot syndromes. Funduscopic examination is initially unremarkable or shows subtle RPE mottling. Multimodal imaging reveals peripapillary hypoautofluorescence and a demarcating line between healthy and affected retina, following a trizonal pattern on OCT and FAF EyeWikiPubMed.

Type 2 (Secondary AZOOR):
Here, AZOOR lesions develop in eyes with other white dot syndromes (e.g., MEWDS, multifocal choroiditis). The initial presentation may mimic those syndromes, but subsequent widespread photoreceptor loss and zonal progression distinguish it. Imaging shows combined features of both conditions, with diffuse outer retinal atrophy overlaying focal white-dot lesions ScienceDirectPubMed.

Type 3 (Chronic/Complex AZOOR):
Advanced cases exhibit irreversible photoreceptor and RPE loss, choroidal atrophy, and attenuated retinal vessels. Clinically, pigmentary disturbances simulate retinitis pigmentosa. OCT demonstrates thinning of the outer and inner nuclear layers, while FAF shows extensive hypoautofluorescence. These cases often follow a prolonged course with bilateral involvement and poor visual prognosis EyeWikiPMC.


Proposed Causes

Note: While the precise cause of AZOOR remains idiopathic, studies suggest several contributory factors.

  1. Autoimmune infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">Inflammation
    An autoimmune process targeting photoreceptors and RPE is supported by female predominance and associations with systemic autoimmune diseases (e.g., thyroiditis, multiple sclerosis) EyeWikiEyeWiki.

  2. Viral Prodrome
    Up to 20% of patients report flu-like symptoms preceding onset, suggesting a viral trigger (e.g., herpesviruses) that may initiate retinal infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation EyeWikiEyeWiki.

  3. Photoreceptor Outer Segment Damage
    Primary injury at the photoreceptor outer segments, as shown by OCT, implies direct photoreceptor toxicity or immune-mediated destruction MDPIjournals.lww.com.

  4. Antiretinal Antibodies
    In one series, all AZOOR patients had detectable antiretinal antibodies on Western blot, although their pathogenic role remains unclear EyeWikiEyeWiki.

  5. White Dot Syndrome Overlap
    AZOOR may represent the end-stage of other white dot syndromes; shared inflammatory pathways could underlie both phenotypes EyeWikiWikipedia.

  6. Genetic Predisposition
    No specific genes have been identified, but familial clustering in rare cases suggests a possible genetic susceptibility journals.lww.com.

  7. Myopia
    Nearsighted individuals appear overrepresented, potentially due to structural retinal vulnerabilities EyeWikiConnectCenter.

  8. Hormonal Influences
    The strong female predominance hints at estrogen-mediated modulation of immune responses in the retina Wikipedia.

  9. Choroidal Vascular Compromise
    Some imaging studies show choriocapillaris hypoperfusion, suggesting ischemic contributions to outer retinal damage EyeWikiEyeWiki.

  10. Immune Complex Deposition
    Deposits in the outer retina may trigger local infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।" data-rx-term="inflammation" data-rx-definition="Inflammation is the body’s response to injury, infection, or irritation, often causing pain, swelling, heat, or redness. সহজ বাংলা: শরীরের প্রদাহ; ব্যথা, ফোলা বা লালভাব হতে পারে।">inflammation and photoreceptor loss, analogous to paraneoplastic retinopathies EyeWikijournals.lww.com.

  11. Environmental Toxins
    Rare exposures (e.g., Candida famata infection) have been reported, though direct causation is unproven Wikipedia.

  12. Oxidative Stress
    Accumulation of reactive oxygen species in photoreceptors could precipitate zonal damage under inflammatory conditions journals.lww.com.

  13. Cytokine Dysregulation
    Elevated pro-inflammatory cytokines in ocular fluids may mediate photoreceptor apoptosis EyeWikijournals.lww.com.

  14. Breakdown of Blood–Retinal Barrier
    Subtle barrier breaches could allow serum components to contact photoreceptors, igniting inflammation EyeWikijournals.lww.com.

  15. Idiopathic Mechanisms
    In many cases, no identifiable trigger is found, underscoring the idiopathic nature of AZOOR Wikipedia.


Symptoms

  1. Photopsia (Flashing Lights)
    Patients describe scintillating or shimmering lights, often preceding or accompanying visual field loss EyeWikijournals.lww.com.

  2. Scotoma (Blind Spots)
    A sudden awareness of areas of missing vision, corresponding to zones of photoreceptor dysfunction EyeWikiMDPI.

  3. Visual Field Defects
    Confrontation and automated perimetry reveal enlarged blind spots, central/paracentral scotomas, or constricted fields EyeWikiEyeWiki.

  4. Mild Reduction in Visual Acuity
    Central acuity is often preserved early but can decline if the macula is involved EyeWikijournals.lww.com.

  5. Delayed Fundus Changes
    Initially, the fundus appears normal; RPE mottling or pigmentary disturbances develop weeks to months later EyeWikijournals.lww.com.

  6. Minimal Anterior Segment Inflammation
    The anterior chamber is usually quiet, though mild vitreous cells may appear in late stages EyeWikiEyeWiki.

  7. Bilateral Progression
    Although often unilateral at onset, up to 76% progress to involve the second eye over years EyeWikiEyeWiki.

  8. Photophobia
    Light sensitivity may accompany photopsias and exacerbate discomfort MalaCards.

  9. Night Vision Difficulties
    Rod dysfunction within affected zones can impair scotopic (low-light) vision MalaCards.

  10. Variable Course and Recovery
    Some patients experience stabilization within six months, while others progress to permanent field loss EyeWikiEyeWiki.


Diagnostic Tests

Physical Examination

  1. Visual Acuity Testing
    Measures central vision; often near normal early in AZOOR but can decline if the macula is affected EyeWikijournals.lww.com.

  2. Pupillary Light Reflex
    Typically normal, helping exclude optic neuropathies Wikipedia.

Manual Functional Tests

  1. Confrontation Visual Fields
    A quick bedside check to identify large scotomas EyeWikiEyeWiki.

  2. Amsler Grid
    Detects central metamorphopsia or paracentral scotomas when patients fixate on a central dot ConnectCenter.

Laboratory and Pathological Tests

  1. Western Blot for Antiretinal Antibodies
    Assesses autoimmune markers; positive in many AZOOR cases but not specific EyeWikiEyeWiki.

  2. Viral Serologies
    Identifies recent infections (e.g., HSV, VZV) in patients with prodromal illness EyeWikiEyeWiki.

  3. Autoimmune Panel (ANA, RF, ENA)
    Screens for systemic autoimmune diseases sometimes associated with AZOOR EyeWikiEyeWiki.

  4. Inflammatory Markers (ESR, CRP)
    May be mildly elevated during active inflammation EyeWikiEyeWiki.

Electrodiagnostic Tests

  1. Full-Field Electroretinography (ffERG)
    Shows global cone-system delays (e.g., 30-Hz flicker implicit time) despite localized lesions EyeWikiMDPI.

  2. Multifocal ERG (mfERG)
    Maps localized outer retinal dysfunction corresponding to scotomas EyeWikiMDPI.

  3. Electro-oculogram (EOG)
    May show reduced light rise but is less sensitive in AZOOR EyeWikiEyeWiki.

  4. Visual Evoked Potentials (VEP)
    Excludes optic nerve involvement by confirming normal cortical responses Wikipedia.

Imaging Tests

  1. Fundus Photography
    Documents subtle RPE changes and pigmentary disturbances over time EyeWikiEyeWiki.

  2. Spectral-Domain OCT (SD-OCT)
    Reveals loss of ellipsoid/interdigitation zones and trizonal outer retinal changes EyeWikiEyeWiki.

  3. Fundus Autofluorescence (FAF)
    Defines lesion extent and documents hyper-/hypoautofluorescence patterns EyeWikiEyeWiki.

  4. Fluorescein Angiography (FA)
    Early normal appearance with late window defects and RPE staining EyeWikiEyeWiki.

  5. Indocyanine Green Angiography (ICG)
    May reveal late hypofluorescence or a trizonal pattern in chronic lesions EyeWikiEyeWiki.

  6. Optical Coherence Tomography Angiography (OCTA)
    Detects secondary choroidal neovascularization in rare complicated cases journals.lww.com.

  7. Adaptive Optics Imaging
    Visualizes cone photoreceptor loss at the lesion border EyeWikiEyeWiki.

  8. B-Scan Ultrasonography / Orbital MRI
    Excludes posterior scleritis and optic nerve lesions when differential diagnosis remains broad EyeWikiWikipedia.

Non-Pharmacological Treatments

Physiotherapy and Electrotherapy Therapies

  1. Eccentric Viewing Training
    This specialized rehabilitation teaches patients to use healthy peripheral retinal areas for fixation, bypassing central scotomas to improve reading speed and activities of daily living. Through guided practice with vision therapists, users learn to orient text or objects into functioning zones, enhancing practical vision despite central defects PMC.

  2. Microperimetry Biofeedback
    Microperimetry assesses scotoma location and retinal sensitivity, then provides auditory or visual feedback as patients attempt to fixate targets in healthier retinal areas. This neuro-visual training promotes cortical adaptation, gradually improving fixation stability and functional peripheral vision Wikipedia.

  3. Computerized Visual Scanning Training
    Using software that displays stimuli across the visual field, this therapy encourages systematic scanning patterns to expand patients’ usable visual field. Over repeated sessions, patients demonstrate reduced reading errors and faster target localization, reflecting enhanced use of peripheral vision Taylor & Francis Online.

  4. Amsler Grid Rehabilitation
    Daily at-home practice with the Amsler grid helps patients detect metamorphopsia and enlarging scotomas early. Regular self-monitoring educates patients about subtle visual changes and promotes timely medical review Wikipedia.

  5. Photobiomodulation (Low-Level Light Therapy)
    Application of near-infrared or red light wavelengths to the retina stimulates mitochondrial cytochrome C oxidase, enhancing cellular energy production and promoting photoreceptor survival. Early human studies suggest potential stabilization of visual field defects in outer retinal degenerations Frontiers.

  6. Transcranial Direct Current Stimulation (tDCS)
    Non-invasive electrodes placed on the scalp deliver weak electrical currents to the visual cortex, modulating cortical excitability and enhancing residual visual function. Preliminary trials show improved contrast sensitivity and transient visual field expansion in retinal disease Wikipedia.

  7. Transcorneal Electrical Stimulation (TES)
    Weak electrical pulses delivered via corneal contact lens electrodes stimulate retinal cells directly, promoting photoreceptor survival and delaying degeneration. Animal and early human studies report preserved retinal thickness and improved electrophysiologic responses PubMed.

  8. Transpalpebral Electrical Stimulation
    Electrical stimulation through the eyelid has been shown to preserve photoreceptor function and induce retinal neurotrophic factor release, offering a non-invasive alternative to TES with promising preclinical results IOVS.

  9. Prism Glasses Adaptation
    Prism lenses shift images from scotomatous zones onto healthier retinal areas, reducing blind-spot impact during reading and mobility tasks. Customized prism placement can significantly improve visual comfort and performance Wikipedia.

  10. Magnification and Contrast Enhancement Devices
    Hand-held or stand magnifiers with adjustable contrast settings assist patients with central scotomas in reading printed text and recognizing faces, leveraging residual peripheral vision for enhanced visual clarity Wikipedia.

Exercise Therapies

  1. Saccadic Eye Movement Training
    Structured exercises prompt rapid, repeated eye jumps (saccades) across target patterns to improve scanning efficiency and reduce time to locate objects in the visual field Taylor & Francis Online.

  2. Smooth Pursuit Practice
    Patients track moving targets smoothly across the field, enhancing oculomotor control and reducing reliance on head movements for visual scanning Wikipedia.

  3. Dynamic Visual Acuity Workouts
    Exercises where patients identify moving letters or symbols help maintain recognition speed and support residual central field function Wikipedia.

  4. Eye-Hand Coordination Drills
    Activities such as ball tosses and touchscreen tracing tasks improve visuomotor integration, critical for tasks like reaching and navigation in compromised visual fields Wikipedia.

  5. Contrast Sensitivity Exercises
    Patients practice distinguishing grayscale gradations on digital apps, aiming to slow contrast sensitivity decline associated with outer retinal damage Wikipedia.

Mind-Body Therapies

  1. Guided Meditation and Relaxation
    Mindfulness practices reduce stress-induced exacerbation of visual symptoms and may modulate inflammatory responses through autonomic nervous system regulation Wikipedia.

  2. Visual Imagery Training
    Patients mentally rehearse scanning environments and visual tasks, enhancing cortical visual mapping and compensatory strategies even without direct eye movement Wikipedia.

  3. Cognitive Behavioral Therapy (CBT)
    CBT addresses anxiety and depression arising from sudden vision loss, teaching coping strategies that support adherence to rehabilitation exercises and improve overall quality of life Wikipedia.

Educational Self-Management

  1. Patient Education Workshops
    Group sessions led by low vision specialists inform patients about AZOOR mechanisms, available therapies, and adaptive techniques, empowering self-management Wikipedia.

  2. Vision Self-Monitoring Diaries
    Structured logs for patients to record daily visual function, photopsia frequency, and symptom triggers enhance self-awareness and facilitate clinician-patient communication during follow-up Wikipedia.


Evidence-Based Drugs

  1. Oral Prednisone (Systemic Corticosteroid)
    Dosage: 1 mg/kg daily (up to 60 mg/day) for 4–6 weeks, then gradual taper; Class: Glucocorticoid; Time: Morning to mimic circadian cortisol rhythm; Side Effects: Weight gain, hypertension, hyperglycemia, mood changes PubMed.

  2. Intravenous Methylprednisolone
    Dosage: 1 g IV daily for 3 days; Class: Glucocorticoid; Time: Once daily infusion; Side Effects: Insomnia, electrolyte imbalance, immunosuppression PubMed.

  3. Mycophenolate Mofetil
    Dosage: 1 g twice daily; Class: Antimetabolite immunosuppressant; Time: Morning and evening; Side Effects: Gastrointestinal upset, leukopenia, increased infection risk PubMed.

  4. Azathioprine
    Dosage: 1–2 mg/kg daily; Class: Purine analog immunosuppressant; Time: Single daily dose; Side Effects: Hepatotoxicity, bone marrow suppression, gastrointestinal discomfort PubMed.

  5. Methotrexate
    Dosage: 7.5–15 mg weekly; Class: Folate antagonist; Time: Weekly administration; Side Effects: Mucositis, hepatotoxicity, pulmonary fibrosis PubMed.

  6. Cyclosporine
    Dosage: 2–5 mg/kg daily in divided doses; Class: Calcineurin inhibitor; Time: Twice daily; Side Effects: Nephrotoxicity, hypertension, tremor PubMed.

  7. Infliximab
    Dosage: 5 mg/kg IV at weeks 0, 2, 6 then every 8 weeks; Class: Anti-TNF-α monoclonal antibody; Side Effects: Infusion reactions, infection risk PubMed.

  8. Rituximab
    Dosage: 375 mg/m² IV weekly × 4 weeks; Class: Anti-CD20 monoclonal antibody; Side Effects: Infusion reactions, neutropenia PubMed.

  9. Methotrexate Pulse Therapy
    Dosage: 1 g/m² IV monthly; Class: Antimetabolite; Side Effects: Hepatotoxicity, mucositis PubMed.

  10. Intravenous Immunoglobulin (IVIG)
    Dosage: 2 g/kg divided over 2–5 days; Class: Immunomodulator; Side Effects: Headache, thromboembolic events PubMed.


Dietary Molecular Supplements

  1. Lutein
    Dosage: 10 mg daily; Functional: Macular pigment enhancer; Mechanism: Filters blue light and acts as antioxidant Wikipedia.

  2. Zeaxanthin
    Dosage: 2 mg daily; Functional: Macular pigment support; Mechanism: Quenches free radicals in photoreceptors Wikipedia.

  3. Omega-3 Fatty Acids (DHA/EPA)
    Dosage: 1 g combined DHA/EPA daily; Functional: Anti-inflammatory; Mechanism: Modulates retinal inflammation, supports photoreceptor membrane integrity Wikipedia.

  4. Vitamin C
    Dosage: 500 mg twice daily; Functional: Water-soluble antioxidant; Mechanism: Neutralizes reactive oxygen species in ocular tissues Wikipedia.

  5. Vitamin E
    Dosage: 400 IU daily; Functional: Lipid-soluble antioxidant; Mechanism: Protects photoreceptor membranes from oxidative damage Wikipedia.

  6. Beta-Carotene (Vitamin A precursor)
    Dosage: 15 mg daily; Functional: Photopigment precursor; Mechanism: Supports visual cycle and photoreceptor health Wikipedia.

  7. Zinc
    Dosage: 80 mg daily; Functional: Trace mineral cofactor; Mechanism: Supports antioxidant enzyme activity and retinal metabolism Wikipedia.

  8. Copper
    Dosage: 2 mg daily; Functional: Cofactor to prevent zinc-induced copper deficiency; Mechanism: Supports superoxide dismutase activity Wikipedia.

  9. Ginkgo Biloba Extract
    Dosage: 120 mg standardized extract daily; Functional: Neuroprotective and vascular modulator; Mechanism: Enhances ocular blood flow and reduces oxidative stress PMC.

  10. Curcumin
    Dosage: 500 mg twice daily; Functional: Anti-inflammatory, antioxidant; Mechanism: Inhibits NF-κB pathway, protects photoreceptors PMC.


Advanced Regenerative and Cell-Based Drugs

  1. Alendronate (Bisphosphonate)
    Dosage: 70 mg orally once weekly; Functional: Antiresorptive; Mechanism: Hypothesized to modulate microglial activation, though evidence for AZOOR is lacking and ocular inflammation is a known adverse effect PubMed.

  2. Recombinant Human Nerve Growth Factor (Cenegermin)
    Dosage: Ophthalmic 0.002% solution, one drop six times daily for 8 weeks; Functional: Neurotrophic; Mechanism: TrkA agonist promoting photoreceptor survival Wikipedia.

  3. Sodium Hyaluronate (Viscosupplementation)
    Dosage: Intravitreal 0.1 mL of 1 mg/mL; Functional: Vitreous substitute drug delivery; Mechanism: Provides mechanical support and sustained release scaffold for adjunct therapies Wikipedia.

  4. Mesenchymal Stem Cell-Derived Exosomes
    Dosage: Experimental intravitreal injection of 50 µL cell-free exosome preparation; Functional: Regenerative; Mechanism: Delivers trophic factors to rescue photoreceptors; clinical trials ongoing Wikipedia.

  5. Voretigene Neparvovec (Gene Therapy)
    Dosage: 1.5 ×10^11 vector genomes subretinal once; Functional: Gene augmentation; Mechanism: Delivers functional RPE65 gene to RPE cells, illustrating potential for genetic outer retinal repair PMC.

  6. Erythropoietin
    Dosage: 33,000 IU IV weekly for 4 weeks; Functional: Neuroprotective cytokine; Mechanism: Activates erythropoietin receptor signaling to inhibit apoptosis in photoreceptors Wikipedia.


Surgical Interventions

  1. Pars Plana Vitrectomy
    Procedure: Three-port removal of vitreous gel to clear inflammatory mediators and perform adjunct treatments; Benefits: Enables direct access for subretinal gene therapy or stem cell delivery Wikipedia.

  2. Scleral Buckling
    Procedure: Silicone band encircling the globe to support peripheral retina; Benefits: Stabilizes retinal architecture, useful if AZOOR leads to secondary tractional detachments Wikipedia.

  3. Retinal Prosthesis (Argus II)
    Procedure: Epiretinal implant converting visual scenes into electrical pulses; Benefits: Provides rudimentary vision in severe outer retinal loss, illustrating potential artificial vision strategies Wikipedia.

  4. Subretinal RPE/Photoreceptor Transplant
    Procedure: Injection or graft of RPE or photoreceptor progenitors derived from stem cells; Benefits: Aims to restore lost outer retinal cells, with early-phase trials reporting safety and integration Wikipedia.

  5. Photodynamic Therapy (Verteporfin PDT)
    Procedure: Intravenous verteporfin followed by retinal laser activation to occlude abnormal vessels; Benefits: May address secondary choroidal neovascularization and limit further outer retinal damage PMC.

Prevention Strategies

  1. Wear 100% UV-Blocking Sunglasses
    Protects retina from cumulative UV damage associated with macular and outer retinal degeneration National Eye Institute.

  2. Use Broad-Brimmed Hats Outdoors
    Further reduces ocular UV exposure, especially during peak sun hours National Eye Institute.

  3. Follow a Diet Rich in Antioxidants
    Include colorful fruits, vegetables, and leafy greens to supply lutein, zeaxanthin, and vitamins C/E Wikipedia.

  4. Avoid Smoking
    Smoking is a known risk factor for retinal oxidative stress and inflammatory ocular diseases Verywell Health.

  5. Manage Systemic Health
    Control hypertension, diabetes, and hyperlipidemia to reduce microvascular stress on the retina Verywell Health.

  6. Regular Eye Examinations
    Early detection of scotomas or fundus changes allows prompt intervention Verywell Health.

  7. Limit Prolonged Screen Time
    Employ the 20-20-20 rule (every 20 minutes, look 20 feet away for 20 seconds) to reduce digital eye strain and maintain tear film PMC.

  8. Ensure Proper Lighting and Contrast
    Use adjustable ambient lighting and screen settings to minimize glare and optimize visual comfort PMC.

  9. Stay Hydrated
    Adequate hydration supports ocular surface health and nutrient delivery to the retina Verywell Health.

  10. Use Low-Vision Aids Early
    Introduce magnifiers and contrast enhancements at first signs of scotoma to maintain independence Wikipedia.


When to See a Doctor

  • Sudden Onset of Photopsias or Scotomas
    Acute flashes of light or new blind spots warrant immediate ophthalmic evaluation Wikipedia.

  • Persistent Blurred Vision or Visual Distortion
    Unresolved changes over 24–48 hours may indicate progressive outer retinal damage Specialty Vision.

  • Changes on Amsler Grid Self-Testing
    New lines or box distortions should trigger prompt follow-up Wikipedia.

  • Worsening of Visual Field Defects
    Rapid expansion of scotomas necessitates repeat imaging and electrophysiology EyeWiki.

  • Development of Pain or Redness
    Suggests possible inflammatory complications or alternative diagnoses requiring urgent care Wikipedia.


What to Do and What to Avoid

What to Do

  1. Maintain scheduled immunosuppressive therapy and follow ophthalmologist’s instructions.

  2. Perform daily low-vision and self-monitoring exercises.

  3. Adhere to dietary supplement regimens as prescribed.

  4. Use protective eyewear for UV and blue-light filtering when outdoors or at screens.

  5. Keep hydration and systemic health optimized.

What to Avoid

  1. Smoking and second-hand smoke exposure.

  2. Unsupervised use of ocular or systemic medications.

  3. High-impact sports or activities risking ocular trauma.

  4. Prolonged exposure to bright, direct sunlight without UV protection.

  5. Excessive screen time without regular breaks.


 Frequently Asked Questions

  1. What is AZOOR?
    AZOOR is a rare inflammatory retinopathy causing acute outer retinal dysfunction with photopsias and visual field defects Wikipedia.

  2. Who is affected?
    It most commonly affects Caucasian females in their mid-thirties but can occur in any demographic Wikipedia.

  3. What causes AZOOR?
    The etiology is unknown; hypotheses include viral triggers and autoimmune photoreceptor attack Wikipedia.

  4. What are the symptoms?
    Sudden photopsias (flashes), central or paracentral scotomas, and mild visual acuity changes Wikipedia.

  5. How is it diagnosed?
    Diagnosis relies on clinical exam, visual field testing, ERG abnormalities, OCT outer retinal disruption, and fundus autofluorescence EyeWiki.

  6. What tests are used?
    Full-field and multifocal ERG, automated perimetry, OCT, fluorescein angiography, and autofluorescence imaging EyeWiki.

  7. What treatments are available?
    High-dose corticosteroids and immunosuppressants are used empirically, though efficacy is variable PubMed.

  8. What is the prognosis?
    Prognosis is variable; some patients stabilize, while others develop bilateral involvement or permanent scotomas ajo.com.

  9. Can AZOOR recur?
    Yes; fellow-eye involvement and recurrences in the same eye are reported in long-term follow-up ajo.com.

  10. Can vision recover?
    Partial recovery of scotomas may occur, but many patients retain some lasting field defects ajo.com.

  11. Is it hereditary?
    No genetic inheritance pattern has been identified; AZOOR is considered nonhereditary Wikipedia.

  12. How is AZOOR different from MEWDS?
    Both are white dot syndromes, but MEWDS often resolves spontaneously with distinct white dots, whereas AZOOR features persistent zonal photoreceptor loss Wikipedia.

  13. Does AZOOR cause blindness?
    Complete blindness is rare, but large scotomas can significantly impair daily activities journals.lww.com.

  14. How common is AZOOR?
    It is extremely rare, with no precise incidence data; Orphanet classifies it as a very rare disorder Orpha.

  15. Where can I find support?
    Patient advocacy groups such as Rare Diseases Info (GARD) offer resources for education and community rarediseases.info.nih.gov.

Disclaimer: Each person’s journey is unique, treatment planlife stylefood habithormonal conditionimmune systemchronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 10, 2025.

  1. Eye Diseases [rxharun.com]
  2. lucentis-epar-product-information-Eye Diseases [rxharun.com]
  3. jesc110 – Eye Diseases [rxharun.com]
  4. 9789240082458-eng [Eye Diseases (rxharun.com)]
  5. d1e1894daab433a1-9ed1066742d1-p67-Watson-et-al-v3 [Eye Diseases (rxharun.com)]
  6. PIIS0161642024000125 [Eye Diseases (rxharun.com)]
  7. OCT_in_Retinal_Diseases_Cozzi_EN [Eye Diseases (rxharun.com)]
  8. Eye76. Corneal Disorders [Eye Diseases (rxharun.com)]
  9. N.R. Galloway [Eye Diseases (rxharun.com)]
  10. OM – Definition & Classification [Eye Diseases (rxharun.com)]
  11. wcms_892937 [Eye Diseases (rxharun.com)]
  12. Diabetes1 [Eye Diseases (rxharun.com)]
  13. specific_eye_conditions [Eye Diseases (rxharun.com)]
  14. CEHJ95_Ocular-Surface-Disorders-1 [Eye Diseases (rxharun.com)]
  15. 17677-68019-2-PB [Eye Diseases (rxharun.com)]
  16. conditions [Eye Diseases (rxharun.com)]
  17. primary-care-approach-to-eye-conditions [Eye Diseases (rxharun.com)]
  18. Symptoms-Related-to-Eye-Diseases-and-Conditions-2 [Eye Diseases (rxharun.com)]
  19. Eye-Disease-Enc-eye-clopedia. [Eye Diseases (rxharun.com)]
  20. MCH-Conf-Mar-2019-6-Sandra-Staffieri-Clinical-Update-Paediatric-Eye-Disease [Eye Diseases (rxharun.com)]
  21. Adult-Hospital-Chapter-18-Eye-Disorders-with-supporting-NEMLC-report-and-reviews-2020-4-Version-1.0-30-September-2024 [Eye Diseases (rxharun.com)]
  22. hod0615i [Eye Diseases (rxharun.com)]
  23. The Cornea and Corneal Disease [Eye Diseases (rxharun.com)]
  24. August 2018 Feature [Eye Diseases (rxharun.com)]
  25. bpj54-pages8-21 [Eye Diseases (rxharun.com)]
  26. KaplanArianeDecember5CommonEye [Eye Diseases (rxharun.com)]
  27. ophthalmology-iv-handout-2016-17 [Eye Diseases (rxharun.com)]
  28. Common-Eye-Diseases-Ceu [Eye Diseases (rxharun.com)]
  29. externalEYE-DISEASE [Eye Diseases (rxharun.com)]
  30. EJHM_Volume 77_Issue 1_Pages 4754-4759 [Eye Diseases (rxharun.com)]
  31. Systemic [Eye Diseases (rxharun.com)]
  32. 9789241516570-eng [Eye Diseases (rxharun.com)]
  33. gp-handbook-common-eye-condition-management [Eye Diseases (rxharun.com)]
  34. Eye Care for FLW- Common Eye related conditions and Service Delivery Framework [Eye Diseases (rxharun.com)]
  35. hod0618i [Eye Diseases (rxharun.com)]
  36. Eye-Disorders-Guideline [Eye Diseases (rxharun.com)]
  37. kevt103 [Eye Diseases (rxharun.com)]
  38. Common Eye Diseases and their Management [Eye Diseases (rxharun.com)]
  39. eyediseases-book-aecp_Eng [Eye Diseases (rxharun.com)]

  1. https://www.aao.org/eye-health/
  2. https://www.nei.nih.gov/
  3. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases
  4. https://www.cdc.gov/vision-health/about-eye-disorders/index.html
  5. https://www.oxfordfamilyvisioncare.com/blog/different-types-of-eye-diseases/
  6. https://www.aoa.org/healthy-eyes/eye-and-vision-conditions
  7. https://www.fda.gov/media/124641/download
  8. https://www.who.int/news-room/fact-sheets/detail/blindness-and-visual-impairment
  9. https://www.nei.nih.gov/learn-about-eye-health/eye-conditions-and-diseases
  10. https://www.ncbi.nlm.nih.gov/books/NBK22174/
  11. https://pubmed.ncbi.nlm.nih.gov/34201117/
  12. https://www.amazon.com/Eye-Book-Complete-Disorders-Hopkins/dp/1421440008
  13. https://www.amazon.com/Eye-Diseases-Disorders-Complete-Guide/dp/1922227323
  14. https://link.springer.com/book/10.1007/978-1-4471-3521-0
  15. https://www.ncbi.nlm.nih.gov/books/NBK582134/
  16. https://www.ncbi.nlm.nih.gov/books/NBK22174/
  17. https://www.ncbi.nlm.nih.gov/mesh?
  18. https://academic.oup.com/ije/article/29/5/951/821890
  19. https://en.wikipedia.org/wiki/Category:Eye_diseases
  20. https://en.wikipedia.org/wiki/Eye_disease
  21. https://medlineplus.gov/eyediseases.html
  22. https://eye.hms.harvard.edu/ormi
  23. https://www.cera.org.au/conditions/
  24. https://jamanetwork.com/journals/jama/fullarticle/2760387
  25. https://www.sciencedirect.com/topics/nursing-and-health-professions/eye-disease
  26. https://biotechhealthcare.com/common-eye-disorders-and-diseases/
  27. https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=85&contentid=p00499
  28. https://pubmed.ncbi.nlm.nih.gov/35715505/
  29. https://www.sciencedirect.com/science/article/pii/S1934590918302315
  30. https://europe.ophthalmologytimes.com/view/bringing-biologics-to-eye-health-regenerative-medicine-for-inflammatory-disorders
  31. https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239
  32. https://www.nibib.nih.gov/
  33. https://www.nei.nih.gov/
  34. https://oxfordtreatment.com/
  35. https://www.nidcd.nih.gov/health/
  36. https://consumer.ftc.gov/articles/
  37. https://www.nccih.nih.gov/health
  38. https://catalog.ninds.nih.gov/
  39. https://www.aarda.org/diseaselist/
  40. https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets
  41. https://www.nibib.nih.gov/
  42. https://www.nia.nih.gov/health/topics
  43. https://www.nichd.nih.gov/
  44. https://www.nimh.nih.gov/health/topics
  45. https://www.nichd.nih.gov/
  46. https://www.niehs.nih.gov/
  47. https://www.nimhd.nih.gov/
  48. https://www.nhlbi.nih.gov/health-topics
  49. https://obssr.od.nih.gov/.
  50. https://www.nichd.nih.gov/health/topics
  51. https://rarediseases.info.nih.gov/diseases
  52. https://beta.rarediseases.info.nih.gov/diseases
  53. https://orwh.od.nih.gov/

Doctor visit helper

Prepare before seeing a doctor

A simple rural-patient checklist to help you explain symptoms clearly, ask better questions, and avoid unsafe self-treatment.

Safety note: This is not a prescription or diagnosis. For severe symptoms, pregnancy danger signs, children with serious illness, chest pain, breathing difficulty, stroke-like weakness, or major injury, seek urgent care.

Which doctor may help?

Start with a registered doctor or the nearest qualified health center.

What to tell the doctor

  • Write when the problem started and how it changed.
  • Bring old prescriptions, investigation reports, and current medicines.
  • Write allergies, pregnancy status, diabetes, kidney/liver disease, and major past illnesses.
  • Bring one family member if the patient is weak, elderly, confused, or a child.

Questions to ask

  • What is the most likely cause of my symptoms?
  • Which danger signs mean I should go to hospital quickly?
  • Which tests are necessary now, and which can wait?
  • How should I take medicines safely and what side effects should I watch for?
  • When should I come for follow-up?

Tests to discuss

  • Vital signs: temperature, pulse, blood pressure, oxygen saturation
  • Basic physical examination by a clinician
  • CBC, urine test, blood sugar, or imaging only when clinically needed

Avoid these mistakes

  • Do not use antibiotics, steroid tablets/injections, or strong painkillers without proper medical advice.
  • Do not hide pregnancy, kidney disease, ulcer, allergy, or blood thinner use.
  • Do not delay emergency care when danger signs are present.

Medicine safety and first-aid guide

This section is for patient education only. It does not replace a doctor, pharmacist, or emergency care.

Safe first steps

  • Avoid heavy lifting, sudden bending, and prolonged bed rest.
  • Use comfortable posture and gentle movement as tolerated.
  • Discuss physiotherapy, X-ray, or MRI only when clinically needed.

OTC medicine safety

  • For mild back pain, pain-relief medicine may be discussed with a doctor or pharmacist.
  • Avoid repeated painkiller use if you have kidney disease, stomach ulcer, uncontrolled blood pressure, or are taking blood thinners.

Avoid these mistakes

  • Do not start antibiotics without a proper medical decision.
  • Do not use steroid tablets or injections casually for quick relief.
  • Do not delay emergency care because of home remedies.

Get urgent help if

  • Back pain with leg weakness, numbness around private area, loss of urine/stool control, fever, cancer history, or major injury needs urgent care.
Medicine names, dose, and timing must be decided by a qualified clinician or pharmacist after checking age, pregnancy, allergy, other diseases, and current medicines.

For rural patients and family caregivers

Patient health record and symptom diary

Write your symptoms, medicines already taken, test results, and questions before visiting a doctor. This note stays on your device unless you print or copy it.

Doctor to discuss: Doctor / qualified healthcare provider
Tests to discuss with doctor
  • Basic vital signs: temperature, pulse, blood pressure, oxygen level if needed
  • Relevant blood, urine, imaging, or specialist tests only after clinical assessment
Questions to ask
  • What is the most likely cause of my symptoms?
  • Which warning signs mean I should go to emergency care?
  • Which tests are really needed now?
  • Which medicines are safe for my age, pregnancy status, allergy, kidney/liver/stomach condition, and current medicines?

Emergency warning signs such as chest pain, severe breathing difficulty, sudden weakness, confusion, severe dehydration, major injury, or loss of bladder/bowel control need urgent medical care. Do not wait for online information.

Safe pathway to proper treatment

Care roadmap for: Acute Zonal Occult Outer Retinopathy (AZOOR)

Use this simple roadmap to understand the next safe steps. It is educational and does not replace examination by a doctor.

Go to emergency care if you notice:
  • Severe or rapidly worsening symptoms
  • Breathing difficulty, chest pain, fainting, confusion, severe weakness, major injury, or severe dehydration
Doctor / service to discuss: Qualified healthcare provider; specialist depends on symptoms and examination.
  1. Step 1

    Check danger signs first

    If danger signs are present, seek emergency care and do not wait for online information.

  2. Step 2

    Record the symptom story

    Write when symptoms started, severity, medicines already taken, allergies, pregnancy status, and test results.

  3. Step 3

    Visit a qualified clinician

    A doctor, nurse, or qualified healthcare provider can examine you and decide which tests or treatment are needed.

  4. Step 4

    Do only useful tests

    Do tests after clinical assessment. Avoid unnecessary tests, random antibiotics, or repeated medicines without diagnosis.

  5. Step 5

    Follow up and return early if worse

    If symptoms worsen, new warning signs appear, or treatment is not helping, return for review quickly.

Rural patient practical tips
  • Take a written symptom diary and all previous prescriptions/test reports.
  • Do not hide medicines already taken, even herbal or over-the-counter medicines.
  • Ask which warning signs mean urgent referral to hospital.

This roadmap is for education. A real diagnosis and treatment plan requires history, examination, and clinical judgment.

RX Patient Help

Ask a health question safely

Write your symptom story. A health professional or site editor can review it before any answer is prepared. This box is not for emergency care.

Emergency first: Severe chest pain, breathing trouble, unconsciousness, stroke signs, severe injury, heavy bleeding, or rapidly worsening symptoms need urgent local medical care now.

Frequently Asked Questions

Is this article a replacement for a doctor?

No. It is educational content only. Patients should consult a qualified clinician for diagnosis and treatment.

When should I seek urgent care?

Seek urgent care for severe symptoms, rapidly worsening condition, breathing difficulty, severe pain, neurological changes, or any emergency warning sign.

A global war against illness

Help this medical guide reach someone who may need it

Share reliable health information with a patient, family member, caregiver, or colleague. Reading and awareness can help people ask better questions and seek appropriate care.

Continue exploring

Explore this topic across the RX Medical Library

Open a focused A–Z pathway or continue with closely related indexed articles. These links are educational and do not replace personal medical care.

Search this topic
Diseases A–Z Drugs A–Z Lab Tests A–Z Cancer A–Z
Diseases A–Z

  Diagnosis and Work Up Diagnosis of peritonsillar abscess is usually made clinically by any of…

Diseases A–Z

Acne Fulminans

Acne fulminans, also known as acute febrile ulcerative acne, is a rare and severe form of…